Fig 1.
CONSORT diagram for follow-up and cardiac events for NCCTG N9831 adjuvant trastuzumab trial. AC, doxorubicin plus cyclophosphamide; CHF, congestive heart failure; LLN, lower limit of normal; LVEF, left ventricular ejection fraction.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.